INTERLEUKIN-1-BETA, HUMAN-LEUKOCYTE ANTIGEN HLA-DR-ALPHA, AND TRANSFORMING GROWTH-FACTOR-BETA EXPRESSION IN ENDOMETRIUM, PLACENTA, AND PLACENTAL MEMBRANES
INTERLEUKIN-1-BETA, HUMAN-LEUKOCYTE ANTIGEN HLA-DR-ALPHA, AND TRANSFORMING GROWTH-FACTOR-BETA EXPRESSION IN ENDOMETRIUM, PLACENTA, AND PLACENTAL MEMBRANES
复制标题
DOI:
10.1016/0002-9378(90)90601-3
复制
发表时间:
1990-11-01
影响因子:
9.8
通讯作者:
TURNER, T
中科院分区:
文献类型:
--
作者:
KAUMA, S;MATT, D;TURNER, T
Maternal immune recognition of the fetal semiallograft appears to be necessary and beneficial for fetal survival and growth. Interleukin-1.beta. and human leukocyte antigen HLA-DR are important for foreign antigen recognition by the immune system, whereas transforming growth factor-.beta. inhibits many of the immunostimulatory properties of interleukin-1.beta.. In this study we found that first-trimester decidua and term placental membranes expressed significantly higher levels of interleukin-1.beta., interleukin-1.beta. messenger ribonucleic acid, and human leukocyte antigen HLA-DR.alpha. messenger ribonucleic acid than proliferative and secretory endometrium. Fetal placenta had little, if any, interleukin-1.beta., interleukin-1.beta. messenger ribonucleic acid, or human leukocyte antigen HLA-DR.alpha. messenger ribonucleic acid expression. All tissues found at the maternal-fetal interface, including first-trimester decidua, placenta, and placental membranes, contained transforming growth factor-.beta. and expressed transforming growth factor-.beta.1 messenger ribonucleic acid. On the basis of these findings, we suggest that the increase in decidual interleukin-1.beta. and human leukocyte antigen HLA-DR.alpha. during pregnancy may be involved in maternal recognition of the fetal semiallograft and that transforming growth factor-.beta. production may regulate the local maternal immune response and prevent rejection of the fetus.